GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suven Pharmaceuticals Ltd (BOM:543064) » Definitions » PB Ratio

Suven Pharmaceuticals (BOM:543064) PB Ratio : 14.73 (As of Mar. 14, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Suven Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-14), Suven Pharmaceuticals's share price is ₹1144.85. Suven Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2024 was ₹77.72. Hence, Suven Pharmaceuticals's PB Ratio of today is 14.73.

The historical rank and industry rank for Suven Pharmaceuticals's PB Ratio or its related term are showing as below:

BOM:543064' s PB Ratio Range Over the Past 10 Years
Min: 3.3   Med: 8.44   Max: 17.1
Current: 14.71

During the past 6 years, Suven Pharmaceuticals's highest PB Ratio was 17.10. The lowest was 3.30. And the median was 8.44.

BOM:543064's PB Ratio is ranked worse than
95.23% of 943 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs BOM:543064: 14.71

During the past 12 months, Suven Pharmaceuticals's average Book Value Per Share Growth Rate was 2.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 20.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 28.00% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Suven Pharmaceuticals was 37.30% per year. The lowest was 20.20% per year. And the median was 27.10% per year.

Back to Basics: PB Ratio


Suven Pharmaceuticals PB Ratio Historical Data

The historical data trend for Suven Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suven Pharmaceuticals PB Ratio Chart

Suven Pharmaceuticals Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial 3.04 10.68 10.30 6.93 8.40

Suven Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 8.40 - 15.10 -

Competitive Comparison of Suven Pharmaceuticals's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Suven Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suven Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Suven Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Suven Pharmaceuticals's PB Ratio falls into.



Suven Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Suven Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=1144.85/77.715
=14.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Suven Pharmaceuticals  (BOM:543064) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Suven Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Suven Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Suven Pharmaceuticals Business Description

Traded in Other Exchanges
Address
No. 202, A-Wing, Galaxy Towers, Plot No.1, Hyderabad Knowledge City, TSIIC, Raidurg, Hyderabad, TG, IND, 500081
Suven Pharmaceuticals Ltd is involved in developing and manufacturing intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology, and chemical companies. The company operates majorly in the Manufacturing (CRAMS) segment, which includes bulk drugs and intermediates under contract services. Its geographical segments include India, the USA, Europe, and the Rest of the World. The majority of the company's revenue comes from the Europe segment.

Suven Pharmaceuticals Headlines

No Headlines